RAPT Therapeutics, Inc.: Company Investigated by the Portnoy Law Firm

Investors can the law firm at no cost to learn more about recovering their losses

LOS ANGELES, March 26, 2023 (GLOBE NEWSWIRE) — advises RAPT Therapeutics, Inc. (“RAPT Therapeutics,” or the “Company”) (NASDAQ: RAPT) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. RAPT investors who lost money on their investment are encouraged to Lesley Portnoy, Esq.

Investors are encouraged to contact an attorney by phone 844-767-8529 or : [email protected], to discuss their legal rights, or to join the case via . The Portnoy Law Firm can provide a free case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On March 14, 2023, the Company disclosed that for its “Phase 2b trial of RPT193 in atopic dermatitis, we now expect topline results in mid-2024 due to recent slower than expected patient enrollment.” Following this news, the price of the Company’s stock dropped.

Please visit us to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against causes caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar


Attorney Advertising

Primary Logo

Leave a Comment